Design, synthesis, docking studies and biological evaluation of novel 2-(1- isonicotinoyl-3-phenyl-1H-pyrazol-4-yl)-3-phenylthiazolidin-4-one derivatives as novel anticancer agents with Aurora-A Kinase inhibition
Research Square (Research Square)